Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Vanderbilt-Ingram Cancer Center
Ottawa Hospital Research Institute
Federico II University
Queen's University, Belfast
University Health Network, Toronto
M.D. Anderson Cancer Center
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital, Bordeaux
Odense University Hospital
Northwestern University
Roswell Park Cancer Institute
Icahn School of Medicine at Mount Sinai
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Geneva
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University Hospital, Bordeaux
Fred Hutchinson Cancer Center
Mayo Clinic
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Mayo Clinic
University of Utah
Roswell Park Cancer Institute
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Swiss Cancer Institute
Icahn School of Medicine at Mount Sinai
University of Illinois at Chicago
University Hospital, Brest
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Icahn School of Medicine at Mount Sinai
OHSU Knight Cancer Institute
Icahn School of Medicine at Mount Sinai
UNC Lineberger Comprehensive Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology